{"References": [{"title": "Gene Therapy for Sickle Cell Disease: A Review of Current and Emerging Approaches", "authors": "Punam Malik, John F. Tisdale", "journal": "Blood Reviews", "year": "2021", "volumes": "48", "first page": "100822", "last page": "", "DOI": "10.1016/j.blre.2021.100822"}, {"title": "Gene Therapy Approaches to Hemoglobinopathies", "authors": "Alessandra Magnani, Olivier Negre, Emmanuelle Magrin, Marina Cavazzana", "journal": "Human Molecular Genetics", "year": "2016", "volumes": "25", "first page": "R52", "last page": "R58", "DOI": "10.1093/hmg/ddw192"}, {"title": "CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia", "authors": "Haydar Frangoul, David Altshuler, M. Domenica Cappellini, Yi-Shan Chen, Jennifer Domm, Brenda K. Eustace, Juergen Foell, Josu de la Fuente, Stephan Grupp, Rupert Handgretinger, Tony W. Ho, Antonis Kattamis, Andrew Kernytsky, Julie Lekstrom-Himes, Amanda M. Li, Franco Locatelli, Markus Y. Mapara, Mariane de Montalembert, Damiano Rondelli, Akshay Sharma, Sujit Sheth, Sandeep Soni, Martin H. Steinberg, Donna Wall, Angela Yen, Selim Corbacioglu", "journal": "New England Journal of Medicine", "year": "2021", "volumes": "384", "first page": "252", "last page": "260", "DOI": "10.1056/NEJMoa2031054"}, {"title": "Gene Therapy for Hemoglobinopathies: Progress and Challenges", "authors": "Donald B. Kohn, Fabrizia Urbinati, Giuliana Ferrari, Roger P. Hollis, Michel Sadelain, Punam Malik, John F. Tisdale", "journal": "Nature Reviews Drug Discovery", "year": "2020", "volumes": "19", "first page": "101", "last page": "118", "DOI": "10.1038/s41573-019-0050-3"}, {"title": "Lentiviral Gene Therapy for Sickle Cell Disease", "authors": "Jean-Antoine Ribeil, Salima Hacein-Bey-Abina, Emmanuel Payen, Alessandra Magnani, Michaela Semeraro, Elisa Magrin, Laure Caccavelli, Benedicte Neven, Philippe Bourget, Wassim El Nemer, Pablo Bartolucci, Leslie Weber, Hervé Puy, Jean-François Meritet, David Grevent, Yves Beuzard, Stany Chrétien, Thibaud Lefebvre, Robert W. Ross, Olivier Negre, Guillaume Veres, Laura Sandler, Sandeep Soni, Mariane de Montalembert, Stéphane Blanche, Philippe Leboulch, Marina Cavazzana", "journal": "New England Journal of Medicine", "year": "2017", "volumes": "376", "first page": "848", "last page": "855", "DOI": "10.1056/NEJMoa1609677"}, {"title": "CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia", "authors": "Daniel E. Bauer, Matthew C. Canver, Stuart H. Orkin", "journal": "New England Journal of Medicine", "year": "2015", "volumes": "372", "first page": "1463", "last page": "1472", "DOI": "10.1056/NEJMra1407876"}, {"title": "Gene Therapy for Sickle Cell Disease: Moving from the Bench to the Bedside", "authors": "Naoya Uchida, Raul Nasnas, John F. Tisdale", "journal": "Blood", "year": "2020", "volumes": "136", "first page": "1", "last page": "10", "DOI": "10.1182/blood.2019000949"}, {"title": "Hematopoietic Stem Cell Transplantation for Sickle Cell Disease: Current Practice and Emerging Trends", "authors": "Shalini Shenoy, Mark Walters", "journal": "Hematology/Oncology Clinics of North America", "year": "2014", "volumes": "28", "first page": "1199", "last page": "1216", "DOI": "10.1016/j.hoc.2014.08.004"}, {"title": "Genetic Therapies for Sickle Cell Disease", "authors": "David A. Williams, John F. Tisdale", "journal": "New England Journal of Medicine", "year": "2020", "volumes": "382", "first page": "1076", "last page": "1078", "DOI": "10.1056/NEJMe2000538"}, {"title": "Genome Editing for Human Gene Therapy", "authors": "Matthew H. Porteus", "journal": "Nature Biotechnology", "year": "2019", "volumes": "37", "first page": "221", "last page": "231", "DOI": "10.1038/s41587-019-0046-x"}]}